TRIM71 and hepatocellular carcinoma: However, in line with later studies (22,25,27,28), we did not observe TRIM71-mediated changes in AGO2 stability in the cell lines tested, including the hepatocellular carcinoma line HepG2 (Supplementary Figure S2A).